Ignite Creation Date:
2025-12-24 @ 1:13 PM
Ignite Modification Date:
2026-02-11 @ 6:28 AM
Study NCT ID:
NCT01569295
Status:
COMPLETED
Last Update Posted:
2020-03-10
First Post:
2012-03-27
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study Evaluating the Efficacy and Safety of Idelalisib in Combination With Bendamustine and Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL) (Tugela )
Sponsor:
Gilead Sciences
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-06-15
Start Date Type:
ACTUAL
Primary Completion Date:
2019-06-10
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-06-10
Completion Date Type:
ACTUAL
First Submit Date:
2012-03-27
First Submit QC Date:
None
Study First Post Date:
2012-04-03
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2017-12-18
Results First Submit QC Date:
None
Results First Post Date:
2018-02-27
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2016-06-06
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2020-03-02
Last Update Post Date:
2020-03-10
Last Update Post Date Type:
ACTUAL